World Journal of Gastrointestinal Oncology

BACKGROUND Type 2 diabetes mellitus (DM) is an independent risk factor for hepatocellular carcinoma (HCC), while insulin is a potent mitogen. Identifying a new therapeutic modality for preventing insulin users from developing HCC is a critical goal for researchers. AIM To investigate whether regular herbal medicine use can decrease HCC risk in DM patients with regular insulin control.

[1]  Jiandong Lu,et al.  Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking , 2022, Frontiers in Pharmacology.

[2]  Tao Zheng,et al.  Aqueous extract of Scrophularia ningpoensis improves insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  N. Chandrashekar,et al.  Baicalein: A review on its anti-cancer effects and mechanisms in lung carcinoma. , 2022, Journal of food biochemistry.

[4]  Haiyang Yu,et al.  Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF/miR-192-5p/CYR61/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment , 2022, Journal of Hematology & Oncology.

[5]  M. Strazzabosco,et al.  Diabetes medications and risk of HCC , 2022, Hepatology.

[6]  Zhengjun Wang,et al.  Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis , 2022, Journal of oncology.

[7]  Qian Gao,et al.  Ophiopogonin-B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways , 2022, Molecular medicine reports.

[8]  Sumei Wang,et al.  Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway , 2022, Molecular carcinogenesis.

[9]  Bin Wang,et al.  Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation , 2021, Pharmaceutical biology.

[10]  Zuojia Liu,et al.  AMPK-Mediated Metabolic Switching Is High Effective for Phytochemical Levo-Tetrahydropalmatine (l-THP) to Reduce Hepatocellular Carcinoma Tumor Growth , 2021, Metabolites.

[11]  Yuliang Cheng,et al.  Echinacea purpurea suppresses the cell survival and metastasis of hepatocellular carcinoma through regulating the PI3K/Akt pathway. , 2021, The international journal of biochemistry & cell biology.

[12]  Chunxiao Wang,et al.  Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis , 2021, Cell cycle.

[13]  Tzung-Yan Lee,et al.  Electroacupuncture attenuates vascular hyporeactivity in a rat model of portal hypertension induced by bile duct ligation , 2021, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

[14]  Zheng Wei,et al.  Oleanolic acid inhibits the migration and invasion of hepatocellular carcinoma cells by promoting microRNA-122 expression. , 2021, Die Pharmazie.

[15]  Jiajia Li,et al.  Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. , 2021, Journal of integrative medicine.

[16]  Hua You,et al.  LSD1‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1‐Induced p62 Transcription in HCC , 2021, Hepatology.

[17]  Jie Chen,et al.  LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro. , 2021, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[18]  F. Chen,et al.  Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Shun-Fa Yang,et al.  Kaempferol inhibits the cell migration of human hepatocellular carcinoma cells by suppressing MMP‐9 and Akt signaling , 2021, Environmental toxicology.

[20]  T. Ikejima,et al.  Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells , 2021, Human & experimental toxicology.

[21]  Xinxin Zhou,et al.  Anemarrhena Saponins Attenuate Insulin Resistance in Rats with High-Fat Diet-Induced Obesity via the IRS-1/PI3K/AKT Pathway. , 2021, Journal of ethnopharmacology.

[22]  Jiamei Yang,et al.  Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma via Down-Regulating the STAT3-Modulated PTTG1 Pathway , 2021, Frontiers in Pharmacology.

[23]  K. Nasiri,et al.  Safflower seed oil improves steroidogenesis and spermatogenesis in rats with type II diabetes mellitus by modulating the genes expression involved in steroidogenesis, inflammation and oxidative stress. , 2021, Journal of ethnopharmacology.

[24]  Lingeng Lu,et al.  Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis , 2021, Scientific Reports.

[25]  Ying Feng,et al.  Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[26]  Gang Yin,et al.  The herbal agent plantamajoside, exerts a potential inhibitory effect on the development of hepatocellular carcinoma , 2021, Experimental and therapeutic medicine.

[27]  Eryun Zhang,et al.  Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice , 2021, Acta pharmaceutica Sinica. B.

[28]  O. Kozawa,et al.  GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway. , 2021, Archives of biochemistry and biophysics.

[29]  J. Pang,et al.  Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma , 2021, Frontiers in Pharmacology.

[30]  Jing Zeng,et al.  Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma , 2021, Frontiers in Pharmacology.

[31]  V. Askari,et al.  Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome: A review , 2021, Phytotherapy research : PTR.

[32]  Hong Zhao,et al.  TKP, a Serine Protease from Trichosanthes kirilowii, Inhibits Cell Proliferation by Blocking Aerobic Glycolysis in Hepatocellular Carcinoma Cells , 2021, Nutrition and cancer.

[33]  Manisha Pandey,et al.  Molecular and Biochemical Pathways of Catalpol in Alleviating Diabetes Mellitus and Its Complications , 2021, Biomolecules.

[34]  P. Zhao,et al.  Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma , 2021, Theranostics.

[35]  Cheng Wang,et al.  Functional lncRNA-miRNA-mRNA Networks in Response to Baicalein Treatment in Hepatocellular Carcinoma , 2021, BioMed research international.

[36]  Wenyu Lin,et al.  Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation , 2021, Journal of cellular and molecular medicine.

[37]  Dong Yan,et al.  Anemarrhena asphodeloides modulates gut microbiota and restores pancreatic function in diabetic rats. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Chun Li,et al.  Astragalus polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages , 2021, Pharmaceutical biology.

[39]  L. Qin,et al.  Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl. , 2020, Journal of ethnopharmacology.

[40]  Chizhi Zhang,et al.  Acupuncture for the Treatment of Liver Cirrhosis: A Meta-analysis , 2020, Gastroenterology research and practice.

[41]  Ruobing Chen,et al.  Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[42]  Ly Le,et al.  Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery , 2020, Biology.

[43]  Yanfen Shi,et al.  Traditional Chinese Medicine Xiaoai Jiedu Recipe Suppresses the Development of Hepatocellular Carcinoma via Regulating the microRNA-29a/Signal Transducer and Activator of Transcription 3 Axis , 2020, OncoTargets and therapy.

[44]  K. Ahn,et al.  An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen) , 2020, Exploration of targeted anti-tumor therapy.

[45]  Kwang-Huei Lin,et al.  Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies , 2020, Cells.

[46]  Shizhang Wei,et al.  Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review , 2020, Frontiers in Pharmacology.

[47]  Haozhen Ren,et al.  Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition , 2020, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[48]  Yueqiu Gao,et al.  Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. , 2020, ACS nano.

[49]  Zhen Wang,et al.  Advances in Pharmacological Activities of Terpenoids , 2020 .

[50]  S. Altekruse,et al.  The association between etiology of hepatocellular carcinoma and race‐ethnicity in Florida , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[51]  J. Bernatonienė,et al.  Flavonoids as Anticancer Agents , 2020, Nutrients.

[52]  M. Hong,et al.  Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[53]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[54]  J. Chen,et al.  Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression , 2019, BioMed research international.

[55]  Fei-Ting Hsu,et al.  Protein Kinase B Inactivation Is Associated with Magnolol-Enhanced Therapeutic Efficacy of Sorafenib in Hepatocellular Carcinoma In Vitro and In Vivo , 2019, Cancers.

[56]  Junn-Liang Chang,et al.  Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression , 2019, Biomolecules.

[57]  Haiyang Yu,et al.  Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[58]  Fengli Li,et al.  H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA. , 2019, Biochemical and biophysical research communications.

[59]  J. González‐Gallego,et al.  Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review , 2019, Nutrients.

[60]  Xin-feng Guo,et al.  Pueraria lobata for Diabetes Mellitus: Past, Present and Future. , 2019, The American journal of Chinese medicine.

[61]  Hui Yan,et al.  Lycium barbarum L. leaves ameliorate type 2 diabetes in rats by modulating metabolic profiles and gut microbiota composition. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[62]  L. Shuo,et al.  Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma. , 2019, Biochemical and biophysical research communications.

[63]  W. Shen,et al.  Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process , 2019, Oncology letters.

[64]  Zhuo Yang,et al.  Dulcitol suppresses proliferation and migration of hepatocellular carcinoma via regulating SIRT1/p53 pathway. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[65]  Y. H. Kwon,et al.  Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells. , 2019, Biochemical and biophysical research communications.

[66]  L. Kóbori,et al.  Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review , 2019, BioMed research international.

[67]  Linhong Fan,et al.  Cinnamomum cassia Presl: A Review of Its Traditional Uses, Phytochemistry, Pharmacology and Toxicology , 2019, Molecules.

[68]  A. El-Karef,et al.  Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. , 2019, Life sciences.

[69]  G. Gores,et al.  A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.

[70]  Yanqin Huang,et al.  Based on network pharmacology to explore the molecular mechanisms of astragalus membranaceus for treating T2 diabetes mellitus. , 2019, Annals of translational medicine.

[71]  E. Sagnelli,et al.  Epidemiological and etiological variations in hepatocellular carcinoma , 2019, Infection.

[72]  Ming Yang,et al.  Electro-Acupuncture Promotes Accumulation of Paclitaxel by Altering Tumor Microvasculature and Microenvironment in Breast Cancer of Mice , 2019, Front. Oncol..

[73]  B. Liu,et al.  Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin‐like growth factor‐1 receptor/phosphatidylinositol‐3‐kinase signaling pathway , 2019, European journal of pharmacology.

[74]  Yanning Liu,et al.  Anti-metastasis traditional Chinese medicine monomer screening system based on perinucleolar compartment analysis in hepatocellular carcinoma cells. , 2019, American journal of translational research.

[75]  R. Hoffman,et al.  Traditional Chinese Medicine (TCM) Astragalus Membranaceus and Curcuma Wenyujin Promote Vascular Normalization in Tumor-derived Endothelial Cells of Human Hepatocellular Carcinoma , 2019, AntiCancer Research.

[76]  Dongwei Zhang,et al.  Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[77]  D. Brenner,et al.  The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma , 2019, International journal of molecular sciences.

[78]  Hong-Xin Cui,et al.  Ameliorative Effect and Mechanism of the Purified Anthraquinone-Glycoside Preparation from Rheum Palmatum L. on Type 2 Diabetes Mellitus , 2019, Molecules.

[79]  Yu-Ting Wu,et al.  Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. , 2019, Journal of ethnopharmacology.

[80]  Jianguo Cao,et al.  8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells , 2019, BMC Cancer.

[81]  G. Casazza,et al.  Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. , 2019, Journal of hepatology.

[82]  Byung-Cheol Lee,et al.  Scutellaria baicalensis Alleviates Insulin Resistance in Diet-Induced Obese Mice by Modulating Inflammation , 2019, International journal of molecular sciences.

[83]  Jiawei Liu,et al.  2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells , 2019, BMC Complementary and Alternative Medicine.

[84]  Yuanyuan Chen,et al.  Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway , 2018, OncoTargets and therapy.

[85]  Guo-Dong Yao,et al.  Timosaponin AIII: A novel potential anti-tumor compound from Anemarrhena asphodeloides , 2018, Steroids.

[86]  Hyun-soo Cho,et al.  The Epigenetic Regulation of HCC Metastasis , 2018, International journal of molecular sciences.

[87]  L. Shan,et al.  Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma , 2018, Journal of Cancer.

[88]  U. Patil,et al.  Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[89]  V. Viswanadha,et al.  Cryptotanshinone (Dsh‐003) from Salvia miltiorrhiza Bunge inhibits prostaglandin E2‐induced survival and invasion effects in HA22T hepatocellular carcinoma cells , 2018, Environmental toxicology.

[90]  U. Gaur,et al.  Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways , 2018, International journal of molecular sciences.

[91]  Zi-fei Yin,et al.  The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways , 2018, Evidence-based complementary and alternative medicine : eCAM.

[92]  X. Xia,et al.  The development of hepatocellular carcinoma in HCV-infected patients treated with DAA: A comprehensive analysis , 2018, Carcinogenesis.

[93]  S. Carradori,et al.  Lycium barbarum polysaccharides: Extraction, purification, structural characterisation and evidence about hypoglycaemic and hypolipidaemic effects. A review. , 2018, Food chemistry.

[94]  A. Boye,et al.  Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocarcinogenesis via modulating TGF-β/TβR and Imp7/8 , 2018, Experimental and therapeutic medicine.

[95]  Guo-Dong Yao,et al.  Phenylpropanoids from the fruit of Crataegus pinnatifida exhibit cytotoxicity on hepatic carcinoma cells through apoptosis induction. , 2018, Fitoterapia.

[96]  Shangping Xing,et al.  Isoviolanthin Extracted from Dendrobium officinale Reverses TGF-β1-Mediated Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Cells via Deactivating the TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways , 2018, International journal of molecular sciences.

[97]  Jing Zhao,et al.  Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes , 2018, Front. Pharmacol..

[98]  H. Rasekh,et al.  Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting , 2018, Nutrition and cancer.

[99]  H. Yoshiji,et al.  Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake , 2018, International journal of cancer.

[100]  Zhaofeng Shi,et al.  Scorpion inhibits epithelial–mesenchymal transition and metastasis of hepatocellular carcinoma , 2018, Experimental biology and medicine.

[101]  Tzong-Ming Shieh,et al.  Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5 , 2018, International journal of molecular sciences.

[102]  Yinglu Feng,et al.  Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy , 2018, Oncoimmunology.

[103]  Wenhua Li,et al.  The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells , 2018, Journal of Experimental & Clinical Cancer Research.

[104]  Xu Li,et al.  Diabetes Mellitus and Risk of Hepatocellular Carcinoma , 2017, BioMed research international.

[105]  S. Chon,et al.  Magnolol protects pancreatic β-cells against methylglyoxal-induced cellular dysfunction. , 2017, Chemico-biological interactions.

[106]  Xiao Han,et al.  Ophiopogonin D alleviates high‐fat diet‐induced metabolic syndrome and changes the structure of gut microbiota in mice , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  Yi-qun Yu,et al.  Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling , 2017, Oncotarget.

[108]  R. Gassen,et al.  Liraglutide, a glucagon‐like peptide‐1 analog, induce autophagy and senescence in HepG2 cells , 2017, European journal of pharmacology.

[109]  C. Nam,et al.  Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide. , 2017, Diabetes & metabolism.

[110]  Y. Tzeng,et al.  Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression. , 2017, Journal of ethnopharmacology.

[111]  Xinwei Han,et al.  The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide , 2017, Oncotarget.

[112]  G. Targher,et al.  Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. , 2017, Annals of translational medicine.

[113]  L. Jeng,et al.  Zanthoxylum avicennae extract enhances GSK‐3β to attenuate β‐catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice , 2017, Environmental toxicology.

[114]  Yue Gao,et al.  Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats , 2017, Scientific Reports.

[115]  Zhao-You Tang,et al.  Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. , 2017, Oncology reports.

[116]  N. Sharma,et al.  Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[117]  Tsai-Chung Li,et al.  Hypoglycemic effects of Trichosanthes kirilowii and its protein constituent in diabetic mice: the involvement of insulin receptor pathway , 2017, BMC Complementary and Alternative Medicine.

[118]  Tetsuya Ikemoto,et al.  Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[119]  Y. Liu,et al.  A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways , 2016, Acta Pharmacologica Sinica.

[120]  P. Brodt.  Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches , 2016, Clinical Cancer Research.

[121]  Jin-jian Lu,et al.  Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen) , 2016, Scientific Reports.

[122]  Yao Tian,et al.  [Effects of Direct Moxibustion of "Ganshu"(BL 18) on the Contents of T cells in Peripheral Blood in Rats with Precancerous Lesion of Primary Hepatocellular Carcinoma]. , 2016, Zhen ci yan jiu = Acupuncture research.

[123]  Weirong Liao,et al.  Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1. , 2016, International journal of molecular medicine.

[124]  S. Snyder,et al.  Anticancer properties of baicalein: a review , 2016, Medicinal Chemistry Research.

[125]  Zhaoshen Li,et al.  Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine. , 2016, Cancer letters.

[126]  Chun-Yen Liu,et al.  The aqueous extract of Chinese medicinal herb Brucea javanica suppresses the growth of human liver cancer and the derived stem-like cells by apoptosis , 2016, Drug design, development and therapy.

[127]  Tao Chen,et al.  Chinese herbal formula QHF inhibits liver cancer cell invasion and migration. , 2016, Experimental and therapeutic medicine.

[128]  Suhuan Liu,et al.  Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase. , 2016, The American journal of Chinese medicine.

[129]  Y. Liu,et al.  The effects of polysaccharides from the root of Angelica sinensis on tumor growth and iron metabolism in H22-bearing mice. , 2016, Food & function.

[130]  Hong-mei An,et al.  Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular Carcinoma , 2016, Molecules.

[131]  Mei-wan Chen,et al.  Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases , 2016, Medicinal research reviews.

[132]  P. Fu,et al.  Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer. , 2015, Cellular and molecular biology.

[133]  Y. Bao,et al.  Juglanthraquinone C Induces Intracellular ROS Increase and Apoptosis by Activating the Akt/Foxo Signal Pathway in HCC Cells , 2015, Oxidative medicine and cellular longevity.

[134]  Ming-dong Wang,et al.  Clinical application of fast-track surgery with Chinese medicine treatment in the devascularization operation for cirrhotic portal hypertension , 2015, Chinese Journal of Integrative Medicine.

[135]  B. Zhai,et al.  Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress , 2015, PloS one.

[136]  I. Fidler,et al.  The challenge of targeting metastasis , 2015, Cancer and Metastasis Reviews.

[137]  A. Maurya,et al.  Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line , 2015, Molecular Biology Reports.

[138]  Yibin Feng,et al.  MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy , 2015, Cancers.

[139]  H. Chung,et al.  Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway. , 2015, International journal of oncology.

[140]  C. Tai,et al.  Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells , 2015, Evidence-based complementary and alternative medicine : eCAM.

[141]  Kaiping Wang,et al.  Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors. , 2015, Food & function.

[142]  R. Hurta,et al.  Magnolol affects expression of IGF-1 and associated binding proteins in human prostate cancer cells in vitro. , 2014, Anticancer research.

[143]  Yi Zhang,et al.  Recent Advances in Astragalus membranaceus Anti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents , 2013, Evidence-based complementary and alternative medicine : eCAM.

[144]  Xiaoqun Duan,et al.  Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[145]  Jiayu Chen,et al.  Glycyrrhiza polysaccharide induces apoptosis and inhibits proliferation of human hepatocellular carcinoma cells by blocking PI3K/AKT signal pathway , 2013, Tumor Biology.

[146]  P. Feliciano.  Metformin in cancer , 2013, Nature Genetics.

[147]  Z. Ren,et al.  Herbal Compound “Songyou Yin” Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness , 2012, Evidence-based complementary and alternative medicine : eCAM.

[148]  Feng Zhang,et al.  Acupuncture Combined with Curcumin Disrupts Platelet-Derived Growth Factor β Receptor/Extracellular Signal-Regulated Kinase Signalling and Stimulates Extracellular Matrix Degradation in Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats , 2012, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

[149]  Chao Lu,et al.  Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway , 2012, Laboratory Investigation.

[150]  Y. Wang,et al.  MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model. , 2012, Journal of ethnopharmacology.

[151]  Feng Zhang,et al.  Acupuncture Combined with Curcumin Attenuates Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats , 2012, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

[152]  Derek LeRoith,et al.  Diabetes, cancer, and metformin: connections of metabolism and cell proliferation , 2011, Annals of the New York Academy of Sciences.

[153]  B. Li,et al.  Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies , 2011, World journal of surgical oncology.

[154]  Changsun Choi,et al.  Ginsenoside Rp1 from Panax ginseng Exhibits Anti-cancer Activity by Down-regulation of the IGF-1R/Akt Pathway in Breast Cancer Cells , 2011, Plant foods for human nutrition.

[155]  Tian Tian,et al.  [Effects of Salviae miltiorrhizae and salvianolic acid B on microcirculation of liver in mice with portal hypertension]. , 2009, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[156]  X. Guan,et al.  CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway , 2008, Oncogene.

[157]  K. Hu,et al.  Effects and mechanisms of silibinin on human hepatoma cell lines. , 2007, World journal of gastroenterology.

[158]  Yi-Chang Su,et al.  Zhi-Fuzi, a Cardiotonic Chinese Herb, a New Medical Treatment Choice for Portal Hypertension? , 2007, Experimental biology and medicine.

[159]  K. Chayama,et al.  Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. , 2007, World journal of gastroenterology.

[160]  J. Chao,et al.  Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells. , 2006, World journal of gastroenterology.

[161]  Dae-Yeul Yu,et al.  Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes. , 2006, European journal of pharmacology.

[162]  L. Chiang,et al.  Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. , 2005, Life sciences.

[163]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[164]  F. Qiu,et al.  Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats. , 2003, Hepatobiliary & pancreatic diseases international : HBPD INT.

[165]  Mary Miu Yee Waye,et al.  Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. , 2002, Life sciences.

[166]  Rui-Chuan Chen,et al.  Induction of differentiation in human hepatocarcinoma cells by isoverbascoside. , 2002, Planta medica.

[167]  C. F. Chen,et al.  Fructus aurantii reduced portal pressure in portal hypertensive rats. , 1995, Life sciences.

[168]  Wogonin Induces Cell Cycle Arrest and Apoptosis of Hepatocellular Carcinoma Cells by Activating Hippo Signaling , 2022, Anti-Cancer Agents in Medicinal Chemistry.

[169]  A. Sahebkar,et al.  A Review of Glycyrrhiza glabra (Licorice) Effects on Metabolic Syndrome. , 2021, Advances in experimental medicine and biology.

[170]  Zonglin Li,et al.  Effect of acupuncture combined with Shenqi Yigan Decoction on liver function and T cell subsets in patients with HBV-induced liver fibrosis. , 2021, American journal of translational research.

[171]  Yen-Lin Chen,et al.  4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling. , 2020, The American journal of Chinese medicine.

[172]  Wenxiao Zhang,et al.  AFM-detected apoptosis of hepatocellular carcinoma cells induced by American ginseng root water extract. , 2018, Micron.

[173]  A. Passantino,et al.  Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review. , 2015, Mini reviews in medicinal chemistry.

[174]  W. Gu,et al.  Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells. , 2014, Oncology reports.

[175]  J. Bruix,et al.  Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. , 2012, Journal of hepatology.

[176]  B. Aggarwal,et al.  Curcumin and liver cancer: a review. , 2012, Current pharmaceutical biotechnology.

[177]  Jie Gu,et al.  [Effect and mechanism of salvianolic acid B in attenuating elevated portal pressure in a rat model of portal hypertension induced by endothelin-1]. , 2007, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[178]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.

[179]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.